Last reviewed · How we verify
Advax2
At a glance
| Generic name | Advax2 |
|---|---|
| Sponsor | Vaxine Pty Ltd |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection (PHASE1, PHASE2)
- Monovalent Recombinant COVID19 Vaccine (PHASE1)
- A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults (PHASE1)
- Recombinant H7 Hemagglutinin Influenza Vaccine Trial (PHASE1)
- Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Advax2 CI brief — competitive landscape report
- Advax2 updates RSS · CI watch RSS
- Vaxine Pty Ltd portfolio CI